Abbott Laboratories (ABT)
Abbott Laboratories is a global healthcare company that produces a wide range of medical products and services, including pharmaceuticals, diagnostics, nutrition products, and medical devices. The company was founded in 1888 and is headquartered in Illinois, United States. Abbott Laboratories operates in over 150 countries and has a diverse workforce of around 100,000 employees.
Company Info
Highlights
$232.01B
$7.99
16.69
4.17
$42.34B
$23.67B
$11.20B
$98.26 - $140.58
$140.57
1.22%
2.69
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Abbott Laboratories (ABT) returned 20.36% year-to-date (YTD) and 31.12% over the past 12 months. Over the past 10 years, ABT delivered an annualized return of 12.80%, outperforming the S&P 500 benchmark at 10.87%.
ABT
20.36%
3.93%
17.46%
31.12%
10.41%
12.80%
^GSPC (Benchmark)
1.30%
12.94%
1.49%
12.48%
15.82%
10.87%
Monthly Returns
The table below presents the monthly returns of ABT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 13.70% | 7.88% | -3.88% | -0.98% | 3.10% | 20.36% | |||||||
| 2024 | 3.29% | 4.85% | -4.20% | -6.30% | -3.57% | 1.68% | 2.49% | 6.92% | 0.65% | -0.09% | 4.76% | -4.77% | 4.82% |
| 2023 | 1.15% | -7.99% | -0.45% | 9.64% | -7.67% | 6.88% | 2.61% | -7.57% | -5.88% | -1.83% | 10.30% | 5.54% | 2.26% |
| 2022 | -9.12% | -5.37% | -1.87% | -3.72% | 3.49% | -7.50% | 0.62% | -5.69% | -5.74% | 2.74% | 8.73% | 2.05% | -20.68% |
| 2021 | 13.33% | -3.08% | 0.05% | 0.57% | -2.86% | -0.62% | 4.75% | 4.46% | -6.52% | 9.53% | -2.42% | 11.90% | 30.53% |
| 2020 | 0.75% | -11.60% | 2.44% | 17.19% | 3.07% | -3.68% | 10.50% | 8.77% | -0.58% | -3.10% | 2.96% | 1.17% | 28.04% |
| 2019 | 1.37% | 6.36% | 2.99% | -0.07% | -4.31% | 10.47% | 3.95% | -2.04% | -1.93% | 0.33% | 2.20% | 1.65% | 22.08% |
| 2018 | 9.44% | -2.94% | -0.68% | -2.52% | 5.85% | -0.88% | 7.94% | 1.98% | 9.75% | -5.64% | 7.41% | -2.32% | 29.06% |
| 2017 | 9.45% | 7.92% | -1.49% | -1.13% | 4.63% | 6.46% | 1.73% | 3.58% | 4.75% | 2.13% | 3.95% | 1.24% | 52.03% |
| 2016 | -15.19% | 2.35% | 7.98% | -6.44% | 1.88% | -0.81% | 14.54% | -6.10% | 0.64% | -6.62% | -2.98% | 0.89% | -12.32% |
| 2015 | -0.05% | 5.83% | -2.20% | 0.71% | 4.70% | 0.99% | 3.78% | -10.65% | -11.19% | 12.03% | 0.27% | -0.02% | 1.87% |
| 2014 | -3.82% | 8.51% | -3.19% | 1.19% | 3.28% | 2.22% | 3.54% | 0.28% | -1.54% | 5.37% | 2.11% | 1.15% | 20.08% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 89, ABT is among the top 11% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abbott Laboratories (ABT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Abbott Laboratories provided a 1.69% dividend yield over the last twelve months, with an annual payout of $2.28 per share. The company has been increasing its dividends for 11 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.28 | $2.20 | $2.04 | $1.88 | $1.80 | $1.44 | $1.28 | $1.12 | $1.06 | $1.04 | $0.96 | $0.88 |
Dividend yield | 1.69% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Monthly Dividends
The table displays the monthly dividend distributions for Abbott Laboratories. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.59 | $0.00 | $0.00 | $0.59 | $0.00 | $1.18 | |||||||
| 2024 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2023 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $2.04 |
| 2022 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $1.88 |
| 2021 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $1.80 |
| 2020 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $1.44 |
| 2019 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $1.28 |
| 2018 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $1.12 |
| 2017 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $0.27 | $0.00 | $0.00 | $1.06 |
| 2016 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $1.04 |
| 2015 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.96 |
| 2014 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.88 |
Dividend Yield & Payout
Dividend Yield
Abbott Laboratories has a dividend yield of 1.69%, which is quite average when compared to the overall market.
Payout Ratio
Abbott Laboratories has a payout ratio of 47.70%, which is quite average when compared to the overall market. This suggests that Abbott Laboratories strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Abbott Laboratories. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abbott Laboratories was 45.66%, occurring on Jul 23, 2002. Recovery took 621 trading sessions.
The current Abbott Laboratories drawdown is 3.42%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.66% | Feb 1, 2002 | 119 | Jul 23, 2002 | 621 | Jan 7, 2005 | 740 |
| -43.29% | Apr 26, 1999 | 191 | Jan 25, 2000 | 193 | Oct 27, 2000 | 384 |
| -35.19% | Mar 25, 1987 | 178 | Dec 4, 1987 | 415 | Jul 27, 1989 | 593 |
| -33.88% | Dec 28, 2021 | 451 | Oct 12, 2023 | 339 | Feb 20, 2025 | 790 |
| -31.61% | Jan 23, 2020 | 42 | Mar 23, 2020 | 17 | Apr 16, 2020 | 59 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Abbott Laboratories over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Abbott Laboratories, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 1.9% positive surprise.
Valuation
The Valuation section provides an overview of how Abbott Laboratories is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ABT, comparing it with other companies in the Medical Devices industry. Currently, ABT has a P/E ratio of 16.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ABT compared to other companies in the Medical Devices industry. ABT currently has a PEG ratio of 4.2. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABT relative to other companies in the Medical Devices industry. Currently, ABT has a P/S ratio of 5.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABT in comparison with other companies in the Medical Devices industry. Currently, ABT has a P/B value of 4.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |